
Faculty, Staff and Student Publications
Publication Date
3-1-2023
Journal
Cancer
Abstract
BACKGROUND: Studies of the immune landscape led to breakthrough trials of programmed death-1 (PD-1) inhibitors for recurrent/metastatic head and neck squamous cell carcinoma therapy. This study investigated the timing, influence of somatic copy-number alterations (SCNAs), and clinical implications of PD-L1 and immune-cell patterns in oral precancer (OPC).
METHODS: The authors evaluated spatial CD3, CD3/8, and CD68 density (cells/mm
RESULTS: Epithelial, but not CD68 immune-cell, PD-L1 expression was detected in 28% of OPCs, correlated with immune-cell infiltration, 9p21.3 loss of heterozygosity (LOH), and inferior oral cancer-free survival (OCFS), notably in OPCs with low CD3/8 cell density, dysplasia, and/or 9p21.3 LOH. High CD3/8 cell density in dysplastic lesions predicted better OCFS and eliminated the excess risk associated with prior oral cancer and dysplasia. PD-L1 and CD3/8 patterns revealed inferior OCFS in PD-L1 high intrinsic induction and dysplastic immune-cold subgroups.
CONCLUSION: This report provides spatial insight into the immune landscape and drivers of OPCs, and a publicly available immunogenomic data set for future precancer interrogation. The data suggest that 9p21.3 LOH triggers an immune-hot inflammatory phenotype; whereas increased 9p deletion size encompassing CD274 at 9p24.1 may contribute to CD3/8 and PD-L1 depletion during invasive transition. The inferior OCFS in PD-L1-high, immune-cold OPCs support the development of T-cell recruitment strategies.
Keywords
Humans, B7-H1 Antigen, Biomarkers, Tumor, Genomics, Head and Neck Neoplasms, Lymphocytes, Tumor-Infiltrating, Mouth Neoplasms, Neoplasm Recurrence, Local, Prospective Studies, Squamous Cell Carcinoma of Head and Neck, Tumor Microenvironment
DOI
10.1002/cncr.34607
PMID
36597662
PMCID
PMC10508302
PubMedCentral® Posted Date
September 2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Medical Genetics Commons, Oncology Commons, Otolaryngology Commons
Comments
Supplementary Material
PMID: 36597662